Skip to main content
Have a personal or library account? Click to login
Latin-American Registry of Cardiovascular Disease and COVID-19: Final Results Cover

References

  1. Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020; 508: 254266. DOI: 10.1016/j.cca.2020.05.044
  2. Uddin M, Mustafa F, Rizvi TA, et al. SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses. 2020; 12(5): 526. DOI: 10.3390/v12050526
  3. Zhang ZL, Hou YL, Li DT, Li FZ. Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for COVID-19: A meta-analysis. J Med Virol. 2021; 93(1): 366374. DOI: 10.1002/jmv.26211
  4. Lascarrou JB, Colin G, Le Thuaut A, et al. Predictors of negative first SARS-CoV-2 RT-PCR despite final diagnosis of COVID-19 and association with outcome. Sci Rep. 2021; 11(1): 2388. DOI: 10.1038/s41598-021-82192-6
  5. Mohamadian M, Chiti H, Shoghli A, et al. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med. 2021; 23(2): e3303. DOI: 10.1002/jgm.3303
  6. Malik YS, Kumar N, Sircar S, et al. Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. Pathogens. 2020; 9(7): 519. DOI: 10.3390/pathogens9070519
  7. World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]; 2023 [cited 2023 Jan 31]. Available from: https://covid19.who.int/
  8. Ugarte-Gil M, Marques C, Alpizar-Rodriguez D, et al. Characteristics associated with Covid-19 in patients with Rheumatic Disease in Latin America: data from the Covid-19 Global Rheumatology Alliance physician-reported registry. Glob Rheumatol. 2020; 1. DOI: 10.46856/grp.10.e003
  9. Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry. Rev Clin Esp. 2020; 220(8): 480494. DOI: 10.1016/j.rce.2020.07.003
  10. Malik P, Patel U, Patel K, et al. Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis. J Med Virol. 2021; 93(2): 11881193. DOI: 10.1002/jmv.26555
  11. Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020; 8(10): 823833. DOI: 10.1016/S2213-8587(20)30271-0
  12. Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA. 2020; 324(8): 799801. DOI: 10.1001/jama.2020.13372
  13. Gómez-Mesa JE, Galindo-Coral S, Montes MC, Muñoz Martin AJ. Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol. 2021; 46(3): 100742. DOI: 10.1016/j.cpcardiol.2020.100742
  14. Schwalb A, Armyra E, Méndez-Aranda M, Ugarte-Gil C. COVID-19 in Latin America and the Caribbean: Two years of the pandemic. J Intern Med. 2022; 292(3): 409427. DOI: 10.1111/joim.13499
  15. Gómez-Mesa JE, Galindo-Coral S, Montes MC, et al. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry. Glob Heart. 2021; 16(1): 14. DOI: 10.5334/gh.925
  16. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2): 377381. DOI: 10.1016/j.jbi.2008.08.010
  17. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95: 103208. DOI: 10.1016/j.jbi.2019.103208
  18. LaRotta J, Escobar O, Ávila-Aguero ML, et al. COVID-19 in Latin America: A Snapshot in Time and the Road Ahead. Infect Dis Ther. 2023; 12: 389410. DOI: 10.1007/s40121-022-00748-z
  19. Halpern B, Louzada MLC, Aschner P, et al. Obesity and COVID-19 in Latin America: A tragedy of two pandemics—Official document of the Latin American Federation of Obesity Societies. Obes Rev. 2021; 22: e13165. DOI: 10.1111/obr.13165
  20. Ríos-Reyna C, Díaz-Ramírez G, Castillo-Ruíz O, Pardo-Buitimea NY, Alemán-Castillo SE. Políticas y estrategias para combatir la obesidad en Latinoamérica [Policies and strategies to combat obesity in Latin America]. Rev Med Inst Mex Seguro Soc. 2022; 60(6): 666674.
  21. Pinto-Filho MM, Paixão GM, Gomes PR, et al. Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study. Heart. 2023; 109: 668673. DOI: 10.1136/heartjnl-2022-321754
  22. Liaqat A, Ali-Khan RS, Asad M, et al. Evaluation of myocardial injury patterns and ST changes among critical and non-critical patients with coronavirus-19 disease. Sci Rep. 2021; 11: 4828. DOI: 10.1038/s41598-021-84467-4
  23. Kassis N, Kumar A, Gangidi S, et al. Prognostic value of initial electrocardiography in predicting long-term all-cause mortality in COVID-19. J Electrocardiol. 2022; 75: 19. DOI: 10.1016/j.jelectrocard.2022.10.003
  24. Patell R, Chiasakul T, Bauer E, Zwicker JI. Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis. Thromb Haemost. 2021; 121(1): 7685. DOI: 10.1055/s-0040-1721664
  25. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 10541062. DOI: 10.1016/S0140-6736(20)30566-3
  26. Lamontagne F, Agarwal A, Rochwerg B, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020; 370: m3379. DOI: 10.1136/bmj.m3379
  27. Kyriakoulis KG, Kollias A, Kyriakoulis IG, et al. Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports. Curr Vasc Pharmacol. 2022; 20(1): 96110. DOI: 10.2174/1570161119666210824160332
  28. Moores LK, Tritschler T, Brosnahan S, et al. Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report. Chest. 2022; 162(1): 213225. DOI: 10.1016/j.chest.2022.02.006
  29. Stanford V, Gresh L, Toledo J, Méndez J, Aldighieri S, Reveiz L. Evidence in decision-making in the context of COVID-19 in Latin America. Lancet Reg Health Am. 2022; 14: 100322. DOI: 10.1016/j.lana.2022.100322
  30. Moreno A, Vargas C, Azocar F, et al. Steroids and mortality in non-critically ill COVID-19 patients: a propensity score-weighted study in a Chilean cohort. Int J Infect Dis. 2021; 112: 124129. DOI: 10.1016/j.ijid.2021.09.038
  31. Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020; 20(10): 11351140. DOI: 10.1016/S1473-3099(20)30434-5
  32. RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021; 384(8): 693704. DOI: 10.1056/NEJMoa2021436
  33. Spina SV, Campos Vieira ML, Herrera CJ, et al. Cardiopulmonary Imaging Utilization and Findings among Hospitalized COVID-19 Patients in Latin America. Glob Heart. 2022; 17(1): 49. DOI: 10.5334/gh.1134
DOI: https://doi.org/10.5334/gh.1272 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 29, 2023
Accepted on: Sep 25, 2023
Published on: Nov 1, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Juan Esteban Gomez-Mesa, Stephania Galindo, Manuela Escalante-Forero, Yorlany Rodas, Andrea Valencia, Eduardo Perna, Alexander Romero, Iván Mendoza, Fernando Wyss, José Luis Barisani, Mario Speranza, Walter Alarco, Noel Alberto Flórez, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.